Skip to content
PILLARS
HomeRecent BillsActionsMore
ExploreElectionsPresidential ActionsPoliticiansTrending Bills
WatchlistSettingsProfile
HomeRecent BillsActionsMore
PILLARS

The bills, politicians, and elections that shape your life, in plain English.

Get the App
Our Receipts
Sources & MethodologyApp DetailsSend Feedback
Browse Bills
Bills That Became LawPassed the HousePassed the SenateBills by Topic
The Legal Stuff
Privacy PolicyTerms of ServiceContact Us
Find Us On
© 2026 Political Pillars Inc.Simplifying politics
Extends Drug Price Negotiation Period
Recent Bills/Extends Drug Price Negotiation Period

Extends Drug Price Negotiation Period

IntroducedN/A
Introduced1 year ago
Intro
Senate
House
Pres
Read twice and referred to the Committee on Finance.
More:Recently Introduced BillsHealthcareSenate Bills
Why This Matters

This bill equalizes the negotiation periods for drug prices between small-molecule and biologic medications, ensuring more time for negotiations.

If you use biologic medications, this bill ensures a minimum of 11 years for price negotiations starting in 2028.
Who this affects
patients · pharmaceutical companies
What changes is this bill making?
  1. 1This bill increases the time for negotiating drug prices for certain medications.
  2. 2It sets a minimum negotiation period of 11 years for biologic drugs after their approval.
  3. 3For the years 2026 and 2027, the negotiation period remains at 7 years for small-molecule drugs.
  4. 4The changes aim to create a fairer process for both types of drugs in the market.
Read the detailed summary

Small Business Advocacy Improvements Act of 2025This bill expands the primary functions and additional duties of the Office of Advocacy of the Small Business Administration to include (1) examining the role of small businesses in the international economy, and (2) representing the views and interests of small businesses before foreign governments and international entities to contribute to regulatory and trade initiatives that may affect small businesses.

Bill Progress1 of 4
Bills must pass the House, Senate, and be signed by the President to become law.
Intro
Senate
House
Pres
IntroducedCurrentJan 31, 2025

Read twice and referred to the Committee on Finance.

Sponsors
See all 4 sponsors
Senate
House
President

The President

Donald Trump
President
Awaiting Vote
Similar Bills
House Bill · HR 1492
1 of 4 · Introduced
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
·Healthcare
Senate Bill · S 1414
1 of 4 · Introduced
Simplifies Approval for Biosimilar Drugs
Expedited Access to Biosimilars Act
·Healthcare
Senate Bill · S 1954
1 of 4 · Introduced
Eases Approval for Biosimilar Drugs
Biosimilar Red Tape Elimination Act
·Healthcare